MoS₂-Plasmonic Hybrid Platforms: Next-Generation Tools for Biological Applications

Area of Science:

• Nanotechnology and Materials Science
• Biomedical Engineering
• Optoelectronics

Background:

• Molybdenum disulfide (MoS2) offers biocompatibility and high surface area.
• Plasmonic nanomaterials provide high optical sensitivity.
• Combining these creates MoS2-plasmonic hybrid systems for enhanced biological applications.

Purpose of the Study:

• To review synthesis strategies for MoS2-plasmonic hybrids.
• To explore applications in biosensing, bioimaging, and phototherapy.
• To discuss challenges and future directions for clinical translation.

Main Methods:

• Exploration of synthesis strategies: seed-mediated growth, in situ deposition, heterojunction formation.
• Analysis of hybrid system properties for signal amplification and targeted therapies.
• Review of applications in cancer/infectious disease biomarker detection and cellular imaging.

Main Results:

• MoS2-plasmonic hybrids enhance signal amplification for sensitive detection and detailed imaging.
• Tailored configurations enable selective photothermal/photodynamic therapies with minimal off-target effects.
• Promising potential demonstrated for accurate tumor ablation via light-induced mechanisms.

Conclusions:

• MoS2-plasmonic hybrids show significant promise for next-generation diagnostics and targeted therapies.
• Overcoming challenges in reproducibility, toxicity, stability, delivery, and manufacturing is crucial for clinical translation.
• Further research is essential to realize the full potential of these hybrid systems in medicine.